SuperworthBionano Genomics shares outstanding BNGO
Diluted shares outstanding, averaged over each quarter, from 2017.
- Latest quarter, to Jun 30, 2026
- 11.5M
- On a year earlier
- +235.5%
- more shares
Bionano Genomics had 11.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 235.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 10.2M | +523% |
| FY2024 | 1.6M | +148% |
| FY2023 | 663.3K | +34% |
| FY2022 | 494.8K | +5% |
| FY2021 | 473.1K | +81% |
| FY2020 | 261.2K | +464% |
| FY2019 | 46.3K | +177% |
| FY2018 | 16.7K | +238% |
| FY2017 | 5K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 11.5M | +236% | |
| Q1 FY26 | 11M | +308% | |
| Q4 FY25 | 10.2M | +523% | |
| Q3 FY25 | 5.3M | +273% | |
| Q2 FY25 | 3.4M | +206% | |
| Q1 FY25 | 2.7M | +206% | |
| Q4 FY24 | 1.6M | +148% | |
| Q3 FY24 | 1.4M | +145% | |
| Q2 FY24 | 1.1M | +114% | |
| Q1 FY24 | 879K | +75% | |
| Q4 FY23 | 663.3K | +34% | |
| Q3 FY23 | 583.4K | +21% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Bionano Genomics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.